Differences in susceptibility to tumor necrosis factor α-induced apoptosis among MCF-7 breast cancer cell variants

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4940-4946

  Burow, Matthew E ^a   Weldon, Christopher B ^a   Tang, Yan ^a   Navar, Gabriel L ^a   Krajewski, Stanislaw ^b   Reed, John C ^b   Hammond, Timothy G ^a   Clejan, Sanda ^a   Beckman, Barbara S ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; CORRELATION FUNCTION; ENZYME ACTIVATION; FLUORESCENCE; HORMONE RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; BREAST NEOPLASMS; CASPASES; CERAMIDES; FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032212405     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Soule, H., Vazquez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1413, 1973.
2. Levenson, A. S., and Jordan, V. C. MCF-7: the first hormone-responsive breast cancer cell line. Cancer Res., 57: 3071-3078, 1997.
3. Osbourne, C. K., Hobbs, K., and Trent, J. M. Biological differences among MCF-7 human breast cancer cell lines from different laboratories. Breast Cancer Res. Treat., 9: 111-121, 1987.
4. Klotz, D. M., Castles, C. G., Fuqua, S. A. W., Spriggs, L. L., and Hill, S. M. Differential expression of wild-type and variant ER mRNAs by stocks of MCF-7 breast cancer cells may account for differences in estrogen responsiveness. Biochem. Biophys. Res. Commun., 210: 609-615, 1995.
5. Villalobos, M., Olea, N., Brotons, J. A., Olea-Serrano, M. F., Ruiz de Almodovar, J. M., and Peraza, V. The E-screen assay: a comparison of different MCF-7 cell stocks. Environ. Health Perspect., 103: 844-850, 1995.
6. Kiguchi, K., Glense, D., Chubb, C. H., Fujiki, H., and Huberman, E. Differential induction of apoptosis in human breast tumor cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A. Cell Growth Differ., 5: 995-1004, 1994.
7. Tewari, M., and Dixit, V. M. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem., 270: 3255-3260, 1995.
8. Chinnaiyan, A. M., Tepper, C. G., Seidin, M. F., O'Rourke, K., Kischkel, F. C., Hellbardt, S., Krammer, P. H., Peter, M. E., and Dixit, V. M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem., 271: 4961-4965, 1996.
9. Liu, Y., Lee, M., Wang, H., Li, Y., Hashimoto, Y., Klaus, M., Reed, J. C., and Zhang, X. K. Retinoic acid receptor β mediates the growth inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell. Biol., 16: 1138-1149, 1996.
10. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995.
11. James, S. Y., Mackay, A. G., and Colston, K. W. Vitamin D derivatives in combination with 9-cis-retinoic acid promotes active cell death in breast cancer cells. J. Mol. Endocrinol., 14: 391-394, 1995.
12. Perry, R. R., Kang, Y., and Greaves, B. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells. Ann. Surg. Oncol., 2: 238-245, 1995.
13. Wang, T. T. Y., and Phang, J. M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res., 55: 2487-2489, 1995.
14. Kyprianou, N., English, H. F., Davidson, N. E., and Isaacs, J. T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res., 51: 162-166, 1991.
15. Blagosklonny, M. V., Schulte, T., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
16. Jeoung, D., Tang, B., and Sonenberg, M. Effects of tumor necrosis factor-α on antimitogenicity and cell cycle-dependent proteins in MCF-7 cells. J. Biol. Chem., 270: 18367-18373, 1995.
17. Cai, Z., Bettaieb, A., Mahdani, N. E., Legres, L. G., Stancou, R., Masliah, J., and Chouaib, S. Alteration of the sphingomyelin/ceramide pathway is associated with resistance of human breast carcinoma MCF-7 cells to tumor necrosis factor-α-mediated cytotoxicity. J. Biol. Chem., 272: 6918-6926, 1997.
18. Belizario, J. E., Tilly, J. L., and Sherwood, S. W. Caffeine potentiates the lethality of tumor necrosis factor in cancer cells. Br. J. Cancer. 67: 1229-1235, 1993.
19. Malorni, W., Rainaldi, G., Tritarelli, E., Rivabene, R., Cianfriglia, M., Lehnert, M., Donelli, G., Peschele, C., and Testa, U. Tumor necrosis factor α is a powerful apoptotic inducer in lymphoid leukemia cells expressing p-170 glycoprotein. Int. J. Cancer, 67: 238-247, 1996.
20. Kean, M. M., Ettenberg, S. A., Lowrey, G. A., Russell, E. K., and Lipkowitz, S. Fas expression and function in normal and malignant breast cell lines. Cancer Res., 56: 4791-4798, 1996.
21. Tang, P., Hung, M., and Klostergard, J. TNF cytotoxicity: effects of HER-2/neu expression and inhibitors of ADP-ribosylation. Lymphokine Cytokine Res., 13: 117-123, 1994.
22. Vandenabeele, P., Declercq, W., Beyaert, R., and Fiers, W. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol., 5: 392-399, 1995.
23. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
24. Hsu, H., Xiong, J., and Goeddel, D. V. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell, 81: 495-504, 1995.
25. Hsu, H., Huang J., Shu, H-B., Baichwal, V., and Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity, 4: 387-396, 1996.
26. Hsu, H., Shu, H-B., Pan, M-G., and Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84: 299-308, 1996.
27. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer P. H., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (FAS/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
28. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell, 85: 803-815, 1996.
29. Hannun, Y. A. Functions of ceramide in coordinating cellular responses to stress. Science (Washington DC), 274: 1855-1859, 1996.
30. Peña, L. A., Fuks, Z., and Kolesnick, R. Stress-induced apoptosis and the sphingomyelin pathway. Biochem. Pharmacol., 53: 615-621, 1997.
31. Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., and Krönke, M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell, 78: 1005-1015, 1994.
32. Nicholson, D. W., and Thornberry, N. A. Caspases: killer proteases. Trends Biochem. Sci., 22: 299-306, 1997.
33. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J., 326: 1-16, 1997.
34. Reed, J. C. Regulation of apoptosis by Bcl-2 family of proteins and its role in cancer and chemoresistance. Curr. Opin. Oncol., 7: 541-546, 1995.
35. Korsmeyer, S. J. Regulators of cell death. Trends Genet., 11: 101-105, 1995.
36. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T., Jones, D. P., and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science (Washington DC), 275: 1129-1132, 1997.
37. Kluck, R. M., Bossy-Wetzel, E., Green, D. R., and Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science (Washington DC), 275: 1132-1136, 1997.
38. Subramanian, T., Tarodi, B., and Chinnadurai, G. p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ., 6: 131-137, 1995.
39. Young, I. T. Proof without prejudice: use of the the Kolmogorov-Smirnov test for the analysis of histograms for flow systems and other sources. J. Histochem. Cytochem., 25: 935-941, 1977.
40. Clejan, S., Dotson, R. S., Wolf, E. W., Corb, M. P., and Ide, C. F. Morphological differentiation of N1E-115 neuroblastoma cells by dimethyl sulfoxide activation of lipid second messengers. Exp. Cell Res., 224: 16-27, 1996.
41. Pagliacci, M. C., Fumi, G., Migliorati, G., Gingnani, F., Riccardi, C., and Nicoletti, I. Cytostatic and cytotoxic effects of tumor necrosis factor a on MCF-7 human breast tumor cells are differentially inhibited by glucocorticoid hormones. Lymphokine Cytokine Res., 12: 439-447, 1993.
42. Vanhaesebroeck, B., Reed, J. C., De Valck, D., Grooten, J., Miyashita, T., Tanaka, S., Beyaert, R., Frans, V. R., and Fiers, W. Effect of bcl-2 proto-oncogene expression on cellular sensitivity to tumor necrosis factor-mediated cytotoxicity. Oncogene, 8: 1075-1081, 1993.
43. 2 in breast carcinoma cells. Oncogene, 10: 2297-2305, 1995.
44. s sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res., 55: 2507-2510, 1995.
45. Wagener, C., Bargou, R. C., Daniel, P. T., Bommert, K., Mapara, M. Y., Royer, H. D., and Dorken, B. Induction of the death-promoting gene Bax-α sensitizes cultured breast cancer cells to drug induced apoptosis. Int. J. Cancer, 67: 138-141, 1996.
46. Bargou, R. C., Wagner, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Royer, H. D., and Dorken, B. Overexpression of the death-promoting gene bax-a which is down-regulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Investig., 97: 2651-2659, 1996.
47. Zhang, J., Alter, N., Reed, J. C., Borner, C., Obeid, L. M., and Hannun, Y. A. Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc. Natl. Acad. Sci. USA, 93: 5325-5328, 1996.
48. Gamen, S., Marzo, I., Anel, A., Piñeiro, A., and Naval, J. CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett., 390: 233-237, 1996.
49. Pronks, P. J., Ramer, K., Amiri, P., and Williams, L. T. Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER. Science (Washington DC), 271: 808-810, 1996.